Sionna Therapeutics to Participate in Upcoming March 2026 Investor Conferences

2026-03-09 10:13:05

Abstract generation in progress

Sionna Therapeutics, a clinical-stage biopharmaceutical company focused on cystic fibrosis, announced its participation in two investor conferences in March 2026. Management will be presenting in fireside chats at the TD Cowen 46th Annual Health Care Conference and the Leerink Partners Global Healthcare Conference 2026. Live webcasts and replays of these presentations will be available on the ‘Investors’ section of Sionna’s website.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.